Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study.
Fiche publication
Date publication
mai 2021
Journal
European journal of clinical pharmacology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie
Tous les auteurs :
Bitar S, Thilly N, Agrinier N
Lien Pubmed
Résumé
The aims of this study were to describe combinations of beta-blockers (BB), renin-angiotensin system (RAS) blockers, and mineralocorticoid receptor antagonist (MRA) prescriptions and their trajectories in heart failure with preserved ejection fraction (HFpEF) patients, and to assess their effect on the three-year all-cause and cardiovascular (CV)-mortality.
Mots clés
Heart failure, Long-term outcomes, Medication, Preserved ejection fraction, Trajectory
Référence
Eur J Clin Pharmacol. 2021 May 10;: